Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Genagon Therapeutics AB

Closing information (x1000 DKK)

Closing information 2022/12 2021/12 2020/12
Turnover 49 Less Arrow 25 Less Arrow 0
Financial expenses 0 Equal arrow 0 More Arrow 1
Earnings before taxes -6,567 More Arrow -6,357 More Arrow -3,867
EBITDA -6,563 More Arrow -6,354 More Arrow -3,862
Total assets 3,796 More Arrow 8,462 Less Arrow 1,835
Current assets 3,781 More Arrow 8,441 Less Arrow 1,835
Current liabilities 456 More Arrow 730 Less Arrow 480
Equity capital 3,340 More Arrow 7,732 Less Arrow -1,898
- share capital 136 More Arrow 137 Less Arrow 92
Employees (average) 3 Equal arrow 3 More Arrow 4

Financial ratios

Fiscal year 2022/12 2021/12 2020/12
Solvency 88.0% More Arrow 91.4% Less Arrow -103.4%
Turnover per employee 16 Less Arrow 8 Less Arrow 0
Profit as a percentage of turnover -13402.0% Less Arrow -25428.0%
Return on assets (ROA) -173.0% More Arrow -75.1% Less Arrow -210.7%
Current ratio 829.2% More Arrow 1156.3% Less Arrow 382.3%
Return on equity (ROE) -196.6% More Arrow -82.2% More Arrow 203.7%
Change turnover 26 Less Arrow 25 Less Arrow 0
Change turnover % 111%
Chg. No. of employees 0 Less Arrow -1 Equal arrow -1
Chg. No. of employees % 0% Less Arrow -25% More Arrow -20%

Total value of public sale

Fiscal year 2022/12 2021/12 2020/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.